Finanzen von Viemed Healthcare Inc (VMD)VMDViemed Healthcare Inc

Evaluating the bottom line, Viemed Healthcare Inc maintains a gross margin of 57.19%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.48%, while the net margin is 3.71%. These profitability ratios, combined with a Return on Equity (ROE) of 10.22%, provide a clear picture of how effectively VMD converts its operational activities into shareholder value.

In the context of the broader market, VMD competes directly with industry leaders such as CYH and BTMD. With a market capitalization of $370.60M, it holds a significant position in the sector. When comparing efficiency, VMD's gross margin of 57.19% stands against CYH's 81.98% and BTMD's 65.38%. Such benchmarking helps identify whether Viemed Healthcare Inc is trading at a premium or discount relative to its financial performance.

Viemed Healthcare's revenue for Q2 2026 was $78.1 million, with a gross margin of 57.7%. The company has also raised its 2026 net revenue guidance to between $314 million and $320 million, reflecting confidence in future growth.